Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic - Wikidata - awgldk - TriplyDB

Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic

Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic

http://www.wikidata.org/entity/Q35451410

about

The promise of new antiepileptic drugs.When is it inappropriate to prescribe psychotropic medication?The use of topiramate in mood stabilization.Effects of topiramate on cognitive function.Behavioural effects of the newer antiepileptic drugs: an update.Epilepsy and suicide: pathogenesis, risk factors, and prevention Psychopharmacology of topiramate: from epilepsy to bipolar disorder.Management of Patients With Unclassified Epileptic Seizures in Outpatient Clinics in Spain. Results of the RETO Study.Modern management of juvenile myoclonic epilepsy.The comorbidity of epilepsy and depression: diagnosis and treatment.Topiramate titration to response: analysis of individualized therapy study (TRAITS).Postmarketing experience with topiramate and cognition.Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.Topiramate rapidly raises brain GABA in epilepsy patients.Topiramate and metabolic acidosis in pediatric epilepsy.Topiramate-induced depression in cases using topiramate for migraine prophylaxis.Topiramate for the treatment of juvenile myoclonic epilepsy.Acute psychotic disorders induced by topiramate: report of two cases

P2860

Q30674774-34D507C7-3ED4-47E0-AC42-FFE3E939A759 Q34570618-A801B1BF-064F-4422-A9C9-8463970F0396 Q34709943-24196468-7927-4EBF-B10D-CE93E3F4DF8C Q35572162-1C75BEDB-30CA-46E5-BBA5-EDB4F510F621 Q35609738-36B11FB7-9E3A-45B9-80CE-3FEF817A3AE5 Q36842197-319885E6-8223-4E99-A2E2-C7BB411B5B73 Q37166152-79BC4E96-634D-46A9-9C08-3A2AB1BE0E65 Q37799816-6B754ABB-84BE-4651-949C-E7F026F2CB92 Q38809047-9C936278-EDBC-48AA-AD04-16AF4A3254D4 Q38872053-FA0C2A6F-03C7-4D2F-BF0A-564371F2F49D Q42597741-27EE7CC6-185A-405B-B16B-1749D76E05D6 Q42660595-BF3EA833-77E2-4683-B1B9-4AA4AC4C04A6 Q42678204-D327E14B-D8AA-412B-8CD7-8CB81637E3ED Q43664156-8CBC6ED2-DC87-4D59-9F61-5B6E03BCA0DB Q43665529-634D59E1-20EB-45D9-8EC9-18281B23D0CC Q45923047-1598FC65-1E33-4727-8E72-599A865E32BB Q46782318-84D45B52-6039-4618-A052-F83F6F43793C Q57086623-782D7BD4-B04D-41D9-983D-5D725AEAB8C1

P2860

Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic

http://www.wikidata.org/entity/Q35451410

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Topiramate in clinical practic ...... n a specialist epilepsy clinic

@ast

Topiramate in clinical practic ...... n a specialist epilepsy clinic

@en

type

label

Topiramate in clinical practic ...... n a specialist epilepsy clinic

@ast

Topiramate in clinical practic ...... n a specialist epilepsy clinic

@en

prefLabel

Topiramate in clinical practic ...... n a specialist epilepsy clinic

@ast

Topiramate in clinical practic ...... n a specialist epilepsy clinic

@en

P1433

Q35451410-8290C8C8-FC4A-4567-95FC-89C4AD9CED3D

P1476

Q35451410-2A49A6BB-D1C9-435C-B387-CFF9769C9EA5

P2093

Q35451410-3B277400-D242-4BA1-951B-6FFAF2973DCD

Q35451410-5658A7D9-566C-4254-BDE7-F615E4403E95

Q35451410-99BCD549-A531-4296-B87F-1FBC3D47F9D1

Q35451410-DEC7307E-B45A-4AA6-B014-5A0457C255CE

P2860

Q35451410-20AE1BCC-75CD-441E-965F-10A423F0EF57

Q35451410-211083B9-EC4D-4D3C-AD34-A02DFA765E4B

Q35451410-2424504D-9A30-45E0-AEF1-828A4DA3E1DF

Q35451410-5A8FF353-882E-44AD-AB0E-B8ED8CBF1508

Q35451410-624B5BDA-D930-423D-92D9-5670CD0749DE

Q35451410-63BE8C4A-913D-4447-B2C5-C95B944404DF

Q35451410-AA194FD8-5E3D-4775-8FF6-8DECA829985A

Q35451410-B86B80B0-2DAD-472E-B4B8-449FE7D4B41E

Q35451410-E273257E-F4C8-4E6A-A505-FE446B504C1F

P304

Q35451410-EBA90147-D681-47EF-9C23-94E4B7B2A099

P31

Q35451410-4B082CBB-7B04-400A-AF82-A90A7E747B7F

P356

Q35451410-5F58DDB4-67EE-4F13-8E70-5253AB4719E5

P407

Q35451410-F3315377-9E34-41D1-ACCB-3C52114BDF1F

P433

Q35451410-AB2CBFB6-C37B-468D-89CA-E218BD78EB7C

P478

Q35451410-143438D8-0610-4ECD-996B-5D2FB1CD0442

P577

Q35451410-3CBB5C4D-5D82-4B06-86EF-9907D07B8048

P5875

Q35451410-E9D0B66E-CBFD-4181-B108-093DFD4CC884

P698

Q35451410-A3BB3445-7CE0-453F-819A-FB932DF7FAD1

P932

Q35451410-CEFA1C18-3598-4FCE-A1F4-DF4854D58C0C

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Topiramate in clinical practic ...... n a specialist epilepsy clinic

@en

P2093

D F Smith

http://www.w3.org/2001/XMLSchema#string

D W Chadwick

http://www.w3.org/2001/XMLSchema#string

M W Kellett

http://www.w3.org/2001/XMLSchema#string

P A Stockton

http://www.w3.org/2001/XMLSchema#string

P2860

New antiepileptic drugs: a systematic review of their efficacy and tolerability.

Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome

Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials.

Practical aspects of the use of topiramate in patients with epilepsy.

An overview of the efficacy and tolerability of new antiepileptic drugs.

Safety of topiramate: adverse events and relationships to dosing.

Preliminary open-label experience with topiramate in primary generalized seizures.

New antiepileptic drugs. Study suggests that under a quarter of patients will still be taking the new drugs after six years.

Drug trials in epilepsy.

P304

759-763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.66.6.759

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12968460

http://www.w3.org/2001/XMLSchema#string

P698

10329750

http://www.w3.org/2001/XMLSchema#string

P932

1736381

http://www.w3.org/2001/XMLSchema#string